Pharmacology, Toxicology and Pharmaceutical Science
Chloroquine
100%
Malaria Falciparum
67%
Antimalarial Agent
54%
Infection
51%
Plasmodium falciparum
49%
Randomized Clinical Trial
46%
Artemether Plus Benflumetol
39%
Diseases
36%
Randomized Controlled Trial
36%
Prevalence
29%
Parasitemia
26%
Mycobacterium Bovis BCG
25%
Artemisinin
22%
Combination Therapy
22%
Diarrhea
22%
Amodiaquine
21%
Benflumetol
21%
Adverse Event
19%
Drug Resistance
15%
Placebo
15%
Human Respiratory Syncytial Virus
14%
Artesunate
12%
Pandemic
12%
Wheezing
12%
Pyrimethamine Plus Sulfadoxine
12%
Atopic Dermatitis
12%
Infectious Agent
12%
Childhood Mortality
11%
Piperaquine
10%
HIV
10%
Prematurity
9%
Base
9%
Giardia intestinalis
8%
Anemia
8%
Clinical Trial
8%
Cryptosporidium
8%
Drug Concentration
8%
Tolerability
7%
Side Effect
7%
Scar Formation
7%
Skin Manifestation
7%
Measles
7%
Pharmacodynamics
7%
Pharmacokinetics
7%
Entamoeba Histolytica
7%
Respiratory Syncytial Virus Infection
7%
Artemether
6%
Dihydroartemisinin
6%
Disease Predisposition
6%
Paracetamol
6%
Nursing and Health Professions
Communication Skill
66%
Neonatal Intensive Care Unit
55%
Health Care Personnel
48%
Self-Efficacy
44%
Outpatient Department
40%
Health Practitioner
27%
Patient Satisfaction
23%
Hemoglobin A1c
22%
Health Care
21%
Insulin Dependent Diabetes Mellitus
18%
Clinical Practice
17%
Adolescent
16%
Audio Recording
16%
Confidence Interval
16%
Patient Care
16%
Total Quality Management
15%
Healthcare System
12%
Health Center
12%
Ward
11%
Chloroquine
11%
Infection
11%
Intention to Treat Analysis
10%
Prevalence
8%
Gestational Age
8%
Prematurity
8%
Arm Circumference
7%
Scar Formation
7%
Diseases
7%
Treatment Outcome
7%
Health Care Facility
7%
Drug Concentration
7%
Treatment Centre
7%
House Call
7%
Outpatient
7%
Neonatal Nurse
7%
Public Hospital
7%
Nursing Care
6%
Pediatrics Patient
6%
Patient Participation
6%
Base
6%
Chickenpox
6%
Skin Injury
6%
Milk Allergy
6%
Tetanus
6%
Diphtheria
6%
Health Outcomes
6%
Self-Awareness
6%
Oxygen Saturation
6%
Systematic Review
6%
Body Composition
6%
Medicine and Dentistry
Randomized Clinical Trial
71%
Infection
45%
Malaria Falciparum
28%
Health Care
23%
Randomized Controlled Trial
23%
Antimalarial Drug Resistance
22%
Diseases
20%
Meta-Analysis
18%
Human Milk
18%
COVID-19
17%
Adverse Event
15%
Wheeze
14%
Human Respiratory Syncytial Virus
14%
Gestational Age
13%
Recrudescence
13%
Odds Ratio
12%
BCG Vaccination
12%
Systematic Review
12%
Neonatal Intensive Care Unit
12%
Heel
12%
Lower Respiratory Tract Infection
12%
Neonatal Infant
12%
Observational Study
11%
Nasal Cannula
10%
Artemisinin
10%
Childhood Mortality
10%
Mycobacterium Bovis BCG
10%
T Lymphocyte Subpopulation
9%
Placebo
9%
Arm
9%
Antimalarial Agent
9%
Cohort Analysis
9%
T-Helper Cell
9%
Prematurity
9%
Continuous Positive Airway Pressure
9%
Pediatrics
8%
Table Salt
8%
Piperaquine
8%
Antibody Response
8%
In Vitro
8%
Cytokine Response
8%
Eczema
8%
High Risk Population
8%
Patient-Data
8%
Plasmodium falciparum
8%
Human Immunodeficiency Virus
8%
Combination Therapy
8%
Asthma
8%
Skin Manifestation
7%
Pertussis
7%
